Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

NCT00561912 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual.

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Decitabine
DRUG: Interferon Alfa-2b

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]